69 Biotech Startups in UK to Watch (and Work for) in 2023
Biotech is rapidly transforming the way we think about and interact with the world around us. Across Europe, but particulartly in UK, Biotech startups are pushing boundaries, fixing problems worth solving, and reshaping the contours of their industry.
As we get into the end of 2023, we've curated a list of the top Biotech startups in UK that are making waves. We update this list monthly by tracking activity in our database of 17,000 technology companies in Europe and sort them dynamically using our Seedtable score, ensuring objectivity.
Changelog
Last update: December 7, 2023. Added companies, investors and rounds. See changelog .
Rankings are calculated using our Seedtable score – a 1 to 100 score that uses quantitative and qualitative data points (examples are money raised or employees over time) to signal the momentum behind a company. A score closer to 100 indicates a company worth watching closely.
Featured companies in Company
89Featured
Biomedical research discovery tool.
-
Latest Funding
$60 Million · Series B
-
Employees
51 to 100
-
Investors
Index Ventures, Index Ventures, Index Ventures, ICONIQ Growth, Pentech Ventures, Pentech Ventures, Marathon VC, Marathon VC
-
Business Model
B2B, SAAS
-
Industries
Health Tech, AI, Biotech, Pharma
-
Locations
London
-
Contact
•••••@causaly.com
Unlock contact info
89Featured
Oophthalmic gene therapy company to treat blinding retinal illnesses.
-
Latest Funding
$120 Million · Series A
-
Employees
1 to 10
-
Investors
Syncona Partners LLP, Syncona Partners LLP
-
Industries
Health Tech, Biotech
-
Locations
London
-
Contact
•••••@beacontx.com
Unlock contact info
84Featured
Mytos is building a fully-automated cell manufacture platform for Pharma
-
Latest Funding
$19 Million · Series A
-
Employees
11 to 50
-
Investors
Buckley Ventures, Wing Venture Capital, IQ Capital Partners
-
Business Model
B2B
-
Industries
Hardware, Biotech, Pharma, Manufacturing
-
Locations
London
-
Contact
•••••@mytos.bio
Unlock contact info
Full list of Biotech startups in UK
84Preclinical stage treatment for geographic atrophy.
-
Latest Funding
$79 Million · Series A
-
Industries
Biotech
-
Locations
London
-
Employees
1 to 10
-
Investors
Forbion Capital Partners, Gimv
-
Contact
•••••@complementtx.com
Unlock contact info
79Portfolio of pharmaceutical research and discovery.
-
Latest Funding
$230 Million · Series C
-
Industries
Biotech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Investors
Patient Square Capital, Rock Springs Capital
-
Contact
•••••@apollotherapeutics.com
Unlock contact info
75Clinical trials platform.
-
Latest Funding
$18 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Valar Ventures, Creandum, Seedcamp, Atomico, Firstminute Capital, Hambro Perks Ltd., Calm/Storm Ventures
-
Contact
•••••@lindushealth.com
Unlock contact info
75Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.
-
Latest Funding
$100 Million · Series B
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Kindred Capital, Octopus Ventures, Amadeus Capital
-
Contact
•••••@oribiotech.com
Unlock contact info
75Quell Therapeutics is a cell therapy company
-
Latest Funding
$160 Million · Series B
-
Industries
Health Tech, Edtech, Biotech, Manufacturing
-
Locations
London
-
Employees
101 to 250
-
Business Model
B2B
-
Investors
AlbionVC, Point72 Ventures
-
Contact
•••••@quell-tx.com
Unlock contact info
75Tropic Biosciences is a pioneering leader in the development of novel high-performing commercial tropical crop varieties and traits.
-
Latest Funding
$35 Million · Series C
-
Industries
Agritech, Biotech, Deep Tech, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Future Planet Capital
-
Contact
•••••@tropicbioscience.com
Unlock contact info
75Gene silencing platform for the creation of programmable, allogeneic cell therapies.
-
Latest Funding
$16 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Investors
Mercia Asset Management, UK Innovation & Science Seed Fund, Calculus Capital, NPIF Maven Equity Finance
-
Contact
•••••@laverocktx.com
Unlock contact info
71Clinical-stage research for alzheimer’s disease.
-
Latest Funding
$59 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Reading
-
Employees
1 to 10
-
Investors
EQT Partners, UCL Technology Fund, Brandon Capital, MPM Capital, Novartis Venture Fund
-
Contact
•••••@astronautx.bio
Unlock contact info
68Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer.
-
Latest Funding
$68 Million · Series C
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
101 to 250
-
Business Model
B2B
-
Investors
Sixth Element Capital, Boxer Capital, Syncona Partners LLP, AlbionVC, Forbion Capital Partners, Invus
-
Contact
•••••@achillestx.com
Unlock contact info
68CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.
-
Latest Funding
$50 Million · Series A
-
Industries
Health Tech, AI, Biotech, Data and Analytics
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
General Catalyst, Khosla Ventures
-
Contact
•••••@charmtx.com
Unlock contact info
68LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine.
-
Latest Funding
$25 Million
-
Industries
Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing
-
Locations
London
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Kindred Capital, Atomico
-
Contact
•••••@labgeni.us
Unlock contact info
68ReViral is a biotechnology company that develops and offers antiviral therapies for patients.
-
Latest Funding
$44 Million · Series C
-
Industries
Health Tech, Biotech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Novo A/S, Andera Partners
-
Contact
•••••@reviral.co.uk
Unlock contact info
68Platform to automate the clinical studies process.
-
Latest Funding
$12 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Playfair, AlbionVC, 11.2 Capital, Delin Ventures
-
Contact
•••••@umed.io
Unlock contact info
68Patent-protected anti-inflammatory painkiller.
-
Latest Funding
$6.3 Million · Series A
-
Industries
Biotech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2C
-
Investors
ITV AdVentures
-
Contact
•••••@flarin.co.uk
Unlock contact info
68User-owned genomics database platform.
-
Latest Funding
$20 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2C
-
Investors
GEM Digital
-
Contact
•••••@genomes.io
Unlock contact info
67Developer of therapeutics for chronic autoimmune and inflammatory diseases.
-
Latest Funding
$39 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Oxford
-
Employees
11 to 50
-
Investors
GSK, Sofinnova Partners, SV Health Investors, Oxford Science Enterprises
-
Contact
•••••@sitryx.com
Unlock contact info
67Drug delivery platform.
-
Latest Funding
$24 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Cambridge
-
Employees
1 to 10
-
Investors
4BIO Capital, UCB Ventures, Business Growth Fund
-
Contact
•••••@vianautis.com
Unlock contact info
64Immuno-oncology company treats cancer with antibodies.
-
Latest Funding
$42 Million
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing, Genetics
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
AlbionVC, Epidarex Capital, Novartis Venture Fund
-
Contact
•••••@epsilogen.com
Unlock contact info
64Quantum simulation platform for drug discovery.
-
Latest Funding
$2.2 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B, SAAS
-
Investors
Ascension Ventures, ACF Investors
-
Contact
•••••@kuano.ai
Unlock contact info
64Cancer treatment predictor software.
-
Latest Funding
$14 Million · Series A
-
Industries
Health Tech, Biotech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures, Octopus Ventures, Fly Ventures
-
Contact
•••••@pearbio.com
Unlock contact info
64Precision software for eye surgery.
-
Latest Funding
$8.1 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Investors
Redalpine
-
Contact
•••••@hypervisionsurgical.com
Unlock contact info
64Protein discovery research and manufacturing.
-
Latest Funding
$20 Million · Series A
-
Industries
Biotech, Deep Tech
-
Locations
London
-
Employees
11 to 50
-
Investors
SYSTEMIQ
-
Contact
•••••@basecamp-research.com
Unlock contact info
64Precision therapeutics discovery platform.
-
Latest Funding
$6.2 Million · Seed
-
Industries
Biotech
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures
-
Contact
•••••@multiomic.uk
Unlock contact info
643D human lung model developer.
-
Latest Funding
$2.4 Million · Seed
-
Industries
Biotech, Deep Tech
-
Locations
London
-
Employees
11 to 50
-
Investors
Pioneer Group, Mercia Asset Management, Midlands Engine Investment Fund
-
Contact
•••••@immuone.com
Unlock contact info
62Oncology treatment plalform.
-
Latest Funding
$35 Million · Series B
-
Industries
Biotech
-
Locations
Cork
-
Employees
1 to 10
-
Investors
Kurma Partners, Enterprise Ireland, Seroba Life Sciences
-
Contact
•••••@shorlapharma.com
Unlock contact info
59Building the future of food, starting with dairy.
-
Latest Funding
$22 Million
-
Industries
Agritech, Foodtech, Biotech, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B, B2C
-
Investors
Entrepreneur First, CPT Capital, Redalpine, Vorwerk Ventures
-
Contact
•••••@betterdairy.co.uk
Unlock contact info
59Daye is a gynecological health company that creates products and services for vaginal treatment.
-
Latest Funding
$12 Million · Series A
-
Industries
Health Tech, Biotech, Manufacturing, Ecommerce, Cannabis
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2C
-
Investors
Index Ventures, Kindred Capital, Khosla Ventures, Hambro Perks Ltd.
-
Contact
•••••@yourdaye.com
Unlock contact info
59Based in London, UK, Hoxton Farms is growing cultivated fat as an ingredient for the meat alternatives industry.
-
Latest Funding
$22 Million · Series A
-
Industries
Foodtech, Biotech, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
BACKED VC, CPT Capital
-
Contact
•••••@hoxtonfarms.com
Unlock contact info
59Biomedical CloudOS data platform.
-
Latest Funding
$60 Million · Series B
-
Industries
Health Tech, Biotech, Data and Analytics, Business Intelligence
-
Locations
London
-
Employees
51 to 100
-
Business Model
B2B, SAAS
-
Investors
Eurazeo, Connect Ventures, Techstars, Tiny VC
-
Contact
•••••@lifebit.ai
Unlock contact info
59Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors.
-
Latest Funding
$6 Million · Seed
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Sofinnova Partners
-
Contact
•••••@myricxpharma.com
Unlock contact info
59OpenCell builds biotech labs in shipping containers with the aim of making biotechnology accessible and affordable.
-
Latest Funding
$8.2 Million
-
Industries
Fintech, Biotech, Proptech & Real Estate, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B, SAAS
-
Investors
Seventure Partners
-
Contact
•••••@opencell.bio
Unlock contact info
59Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure.
-
Latest Funding
$12 Million · Series A
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Business Growth Fund, Parkwalk Advisors, Deepbridge Capital
-
Contact
•••••@pathfindermed.com
Unlock contact info
59We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins.
-
Latest Funding
$40 Million · Series A
-
Industries
Health Tech, Biotech, Pharma, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures, Bessemer Venture Partners
-
Contact
•••••@peptone.io
Unlock contact info
59Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies.
-
Latest Funding
$10 Million
-
Industries
Health Tech, Biotech, Robotics, Manufacturing, Business Intelligence
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Y Combinator, Pi Campus
-
Contact
•••••@sixfold.bio
Unlock contact info
59At-home fertility treatment.
-
Latest Funding
$3.2 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2C
-
Investors
Octopus Ventures, Calm/Storm Ventures, QVentures
-
Contact
•••••@beafertility.com
Unlock contact info
59Developer of cutting-edge DNA techniques to monitor biodiversity.
-
Latest Funding
$13 Million · Series A
-
Industries
Biotech
-
Locations
London
-
Employees
11 to 50
-
Investors
SYSTEMIQ, BNP Paribas, Green Angel Ventures, Triple Point Ventures
-
Contact
•••••@naturemetrics.co.uk
Unlock contact info
56F2G discovers and develops novel drugs for the treatment of life-threatening fungal diseases.
-
Latest Funding
$70 Million
-
Industries
Health Tech, Biotech, Pharma, Genetics
-
Locations
Manchester
-
Employees
251 to 500
-
Business Model
B2B
-
Investors
Sofinnova Partners, Novo A/S, Forbion Capital Partners
-
Contact
•••••@f2g.com
Unlock contact info
56Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
-
Latest Funding
$56 Million · Series B
-
Industries
Health Tech, AI, Biotech, Pharma, Data and Analytics, Business Intelligence
-
Locations
Cambridge
-
Employees
51 to 100
-
Business Model
B2B, SAAS
-
Investors
Balderton Capital, Atomico, btov Partners, Amadeus Capital
-
Contact
•••••@healx.io
Unlock contact info
56Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers.
-
Latest Funding
$67 Million
-
Industries
Health Tech, Biotech, Deep Tech, Manufacturing
-
Locations
Cambridge
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Seventure Partners, Cambridge Innovation Capital
-
Contact
•••••@microbiotica.com
Unlock contact info
56MiroBio is Harnessing the natural control mechanisms of the immune system.
-
Latest Funding
$97 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech
-
Locations
Oxford
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Medicxi, Oxford Science Enterprises
-
Contact
•••••@mirobio.com
Unlock contact info
56Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.
-
Latest Funding
$10 Million · Series A
-
Industries
Health Tech, Biotech, Deep Tech
-
Locations
Cambridge
-
Employees
101 to 250
-
Business Model
B2B
-
Investors
Astellas Venture Management, Ahren Innovation Capital, Parkwalk Advisors
-
Contact
•••••@mogrify.co.uk
Unlock contact info
56ONI is a pioneer of super-resolution microscopy, making this advanced technology accessible to new generations of researchers.
-
Latest Funding
$75 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech, Robotics, Manufacturing, Developer Tools
-
Locations
Oxford
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Axon Ventures, Oxford Science Enterprises
-
Contact
•••••@oni.bio
Unlock contact info
56Lab-quality diagnostics for anyone, anywhere, at any time.
-
Latest Funding
$85 Million · Series C
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
Oxford
-
Employees
51 to 100
-
Business Model
B2B
-
Investors
Oxford Science Enterprises
-
Contact
•••••@oslerdiagnostics.com
Unlock contact info
56Oxford Nanopore Technologies develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.
-
Latest Funding
$280 Million
-
Industries
Health Tech, Biotech, Pharma, Robotics, Manufacturing, Genetics
-
Locations
Oxford
-
Employees
251 to 500
-
Business Model
B2B
-
Investors
Wellington Management
-
Contact
•••••@nanoporetech.com
Unlock contact info
56Physiological upregulation therapy to treat neurodegenerative diseases.
-
Latest Funding
$5.1 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
Cambridge
-
Employees
11 to 50
-
Investors
SV Health Investors
-
Contact
•••••@harnesstx.com
Unlock contact info
54Epoch develops natural solutions to unnatural problems. First up: enzymes that transform plastics into circular chemicals.
-
Latest Funding
$11 Million · Seed
-
Industries
Biotech, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Lowercarbon Capital, BoxGroup, Amadeus Capital, Ascension Ventures, Plug and Play Spain
-
Contact
•••••@epochbiodesign.com
Unlock contact info
54FabricNano is a cell-free biomanufacturing company that develops biocatalysts to unlock the future of biochemistry.
-
Latest Funding
$13 Million · Series A
-
Industries
Biotech, Energy & Nuclear, Robotics, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Hoxton Ventures, BACKED VC, Atomico, Entrepreneur First
-
Contact
•••••@fabricnano.com
Unlock contact info
54Pheon Therapeutics is an Antibody-Drug Conjugate (ADC) specialist that creates ADCs for a variety of difficult-to-treat cancers.
-
Latest Funding
$68 Million · Series A
-
Industries
Health Tech, Biotech, Deep Tech, Pharma
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Forbion Capital Partners
-
Contact
•••••@pheontx.com
Unlock contact info
54Computer simulation to understand drug-bacteria interactions.
-
Latest Funding
$5 Million · Seed
-
Industries
Biotech
-
Locations
London
-
Employees
1 to 10
-
Investors
Hoxton Ventures, Sofinnova Partners
-
Contact
•••••@biocortex.co.uk
Unlock contact info
54Digital-twin simulator.
-
Latest Funding
$3.1 Million · Pre Seed
-
Industries
Biotech, Supply Chain & Logistics
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Crane Venture Partners
-
Contact
•••••@quaisr.io
Unlock contact info
54Developer of innovative treatment for muscle wasting disorders.
-
Latest Funding
$6.1 Million · Series A
-
Industries
Biotech, Pharma
-
Locations
London
-
Employees
1 to 10
-
Investors
Mankind Pharma
-
Contact
•••••@actimedtherapeutics.com
Unlock contact info
54Developer of novel Treg therapies to treat inflammatory disorders.
-
Latest Funding
$840 Thousand · Pre Seed
-
Industries
Health Tech, Biotech
-
Locations
London
-
Employees
1 to10
-
Business Model
B2C
-
Investors
Deep Science Ventures, Wren Capital
-
Contact
•••••@bastion-tx.com
Unlock contact info
53Gene and cell therapy manufacturing.
-
Latest Funding
$66 Million · Series A
-
Industries
Biotech
-
Locations
London
-
Employees
11 to 50
-
Contact
•••••@ascend-gctx.com
Unlock contact info
51Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.
-
Latest Funding
$100 Million · Series B
-
Industries
Health Tech, Biotech, Deep Tech, Business Intelligence
-
Locations
Cambridge
-
Employees
101 to 250
-
Business Model
B2B
-
Investors
BlueYard Capital, Metaplanet Holdings
-
Contact
•••••@bit.bio
Unlock contact info
51Eagle Genomics is a enterprise software solutions company to enable the management, orchestration and exploitation of life sciences data.
-
Latest Funding
$3.6 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
Cambridge
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Granpool Innovative Investments, ETF Partners
-
Contact
•••••@eaglegenomics.com
Unlock contact info
51Nuclera makes biology accessible through desktop enzymatic protein and gene synthesis.
-
Latest Funding
$16 Million · Series B
-
Industries
Biotech, Deep Tech, Manufacturing
-
Locations
Cambridge
-
Employees
11 to 50
-
Business Model
B2B
-
Investors
Future Planet Capital, Amadeus Capital, Verve Ventures
-
Contact
•••••@nuclera.com
Unlock contact info
51Small molecules to increase tumor detection by the immune system.
-
Latest Funding
$49 Million · Series B
-
Industries
Biotech
-
Locations
Oxford
-
Employees
1 to 10
-
Investors
Earlybird Venture Capital
-
Contact
•••••@greywolftherapeutics.com
Unlock contact info
51Anti-cancer drug developer.
-
Latest Funding
$28 Million · Series A
-
Industries
Biotech
-
Locations
Cambridge
-
Employees
101 to 250
-
Investors
Syncona Partners LLP, Cambridge Innovation Capital
-
Contact
•••••@mosaic-tx.com
Unlock contact info
51DNA synthesis technology researcher.
-
Latest Funding
$24 Million · Series B
-
Industries
Biotech
-
Locations
Cambridge
-
Employees
11 to 50
-
Investors
Foresite Capital
-
Contact
•••••@evonetix.com
Unlock contact info
51Genomics company building safer cell and gene therapies.
-
Latest Funding
$15 Million · Series A
-
Industries
Health Tech, Biotech
-
Locations
Cambridge
-
Employees
1 to 10
-
Investors
Tencent, Illumina Ventures
-
Contact
•••••@brokenstringbio.com
Unlock contact info
51Advanced gene editing paltform for rare diseases.
-
Latest Funding
$6.8 Million · Seed
-
Industries
Health Tech, Biotech
-
Locations
Manchester
-
Employees
1 to 10
-
Investors
Octopus Ventures, Northern Gritstone
-
Contact
•••••@pencilbiosciences.com
Unlock contact info
50Arborea is industrialising photosynthesis to expand the world’s food supply
-
Latest Funding
$4.1 Million · Seed
-
Industries
Climate Tech & Green Tech, Foodtech, Biotech, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Business Growth Fund
-
Contact
•••••@arborea.io
Unlock contact info
50Baseimmune is a biotech startup founded to create the next generation of vaccines.
-
Latest Funding
$4.8 Million · Seed
-
Industries
Health Tech, Biotech, Deep Tech, Pharma, Manufacturing
-
Locations
London
-
Employees
1 to 10
-
Business Model
B2B
-
Investors
Hoxton Ventures, Cherry Ventures, Maki.vc, Creator Fund
-
Contact
•••••@baseimmune.co.uk
Unlock contact info
50dnaNUDGE aims to nudge people towards a better lifestyle based on their DNA.
-
Latest Funding
$60 Million · Series A
-
Industries
Health Tech, Biotech, Manufacturing
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B
-
Contact
•••••@dnanudge.com
Unlock contact info
50Foodsteps is a london-based startup that has developed a platform to help the food sector reduce its carbon footprint.
-
Latest Funding
$4.1 Million
-
Industries
Climate Tech & Green Tech, Health Tech, Agritech, Foodtech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Octopus Ventures, Ascension Ventures, Metaplanet Holdings
-
Contact
•••••@foodsteps.earth
Unlock contact info
50Gardin develops optical phenotyping technology and analytics to optimise food production.
-
Latest Funding
$11 Million · Seed
-
Industries
Agritech, Foodtech, Biotech, Data and Analytics
-
Locations
London
-
Employees
11 to 50
-
Business Model
B2B, SAAS
-
Investors
Molten Ventures, Seedcamp, MMC Ventures
-
Contact
•••••@gardin.co.uk
Unlock contact info